(ADI) Analog Devices - Overview
Sector: Technology | Industry: Semiconductors | Exchange: NASDAQ (USA) | Market Cap: 208.843m USD | Total Return: 78.7% in 12m
Avg Turnover: 2.03B
EPS Trend: -35.1%
Qual. Beats: 2
Rev. Trend: -9.2%
Qual. Beats: 9
Warnings
Below Avwap Earnings
Tailwinds
Pead, Confidence
Analog Devices, Inc. (ADI) designs and manufactures a broad portfolio of high-performance analog, mixed-signal, and digital signal processing integrated circuits. Its core technology facilitates the conversion and conditioning of real-world phenomena-such as temperature, pressure, and sound-into digital data for use in electronic systems. The company distributes its products globally across the industrial, automotive, communications, and healthcare sectors.
The semiconductor industry is characterized by high research and development intensity, with ADI focusing on high-margin, long-lifecycle products that are often deeply embedded in industrial infrastructure. Unlike the consumer-centric memory or processor markets, the analog sector typically experiences lower volatility due to the specialized nature of signal-chain hardware and the high cost for customers to switch suppliers.
Investors can further examine these competitive moats and historical performance metrics by reviewing the detailed data available on ValueRay.
Headquartered in Wilmington, Massachusetts, the company operates through a diverse go-to-market strategy involving direct sales, third-party distributors, and digital channels. Its product range includes power management tools, radio frequency ICs, and micro-electro-mechanical systems (MEMS) used for precision sensing in aerospace and defense applications.
- Industrial automation demand recovery drives significant revenue growth in core segments
- Automotive electrification increases semiconductor content per vehicle for power management
- High performance analog margins benefit from long product lifecycles and low competition
- Inventory normalization across distribution channels stabilizes quarterly earnings and cash flow
- Global trade policy shifts impact manufacturing costs and access to Chinese markets
| Net Income: 3.31b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 2.56 > 1.0 |
| NWC/Revenue: 26.32% < 20% (prev 29.51%; Δ -3.20% < -1%) |
| CFO/TA 0.11 > 3% & CFO 5.11b > Net Income 3.31b |
| Net Debt (5.32b) to EBITDA (6.19b): 0.86 < 3 |
| Current Ratio: 1.75 > 1.5 & < 3 |
| Outstanding Shares: last quarter (490.5m) vs 12m ago -1.55% < -2% |
| Gross Margin: 64.49% > 18% (prev 58.76%; Δ 5.73% > 0.5%) |
| Asset Turnover: 26.74% > 50% (prev 20.74%; Δ 6.00% > 0%) |
| Interest Coverage Ratio: 12.38 > 6 (EBIT TTM 4.23b / Interest Expense TTM 341.7m) |
| A: 0.07 (Total Current Assets 7.81b - Total Current Liabilities 4.46b) / Total Assets 47.9b |
| B: 0.24 (Retained Earnings 11.5b / Total Assets 47.9b) |
| C: 0.09 (EBIT TTM 4.23b / Avg Total Assets 47.6b) |
| D: 2.38 (Book Value of Equity 33.7b / Total Liabilities 14.2b) |
| Altman-Z'' = 4.33 = AA |
| DSRI: 1.14 (Receivables 2.05b/1.38b, Revenue 12.7b/9.82b) |
| GMI: 0.91 (GM 58.76% / 64.49%) |
| AQI: 0.95 (AQ_t 0.77 / AQ_t-1 0.81) |
| SGI: 1.30 (Revenue 12.7b / 9.82b) |
| TATA: -0.04 (NI 3.31b - CFO 5.11b) / TA 47.9b) |
| Beneish M = -2.81 (Cap -4..+1) = A |
As of June 08, 2026, the stock is trading at USD 401.39 with a total of 7,215,360 shares traded.
Over the past week, the price has changed by -2.75%,
over one month by -1.48%,
over three months by +25.89% and
over the past year by +78.69%.
Analog Devices has received a consensus analysts rating of 4.13. Therefore, it is recommended to buy ADI.
- StrongBuy: 16
- Buy: 5
- Hold: 9
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 451.1 | 12.4% |
P/E Trailing = 63.7088
P/E Forward = 34.6021
P/S = 16.7331
P/B = 6.1092
P/EG = 0.9262
Revenue TTM = 12.7b USD
EBIT TTM = 4.23b USD
EBITDA TTM = 6.19b USD
Long Term Debt = 7.24b USD (from longTermDebt, last quarter)
Short Term Debt = 1.45b USD (from shortTermDebt, last quarter)
Debt = 8.76b USD (from shortLongTermDebtTotal, last quarter) + Leases 72.9m
Net Debt = 5.32b USD (calculated: Debt 8.76b - CCE 3.44b)
Enterprise Value = 214b USD (209b + Debt 8.76b - CCE 3.44b)
Interest Coverage Ratio = 12.38 (Ebit TTM 4.23b / Interest Expense TTM 341.7m)
EV/FCF = 46.91x (Enterprise Value 214b / FCF TTM 4.57b)
FCF Yield = 2.13% (FCF TTM 4.57b / Enterprise Value 214b)
FCF Margin = 35.83% (FCF TTM 4.57b / Revenue TTM 12.7b)
Net Margin = 26.01% (Net Income TTM 3.31b / Revenue TTM 12.7b)
Gross Margin = 64.49% ((Revenue TTM 12.7b - Cost of Revenue TTM 4.52b) / Revenue TTM)
Gross Margin QoQ = 67.33% (prev 64.71%)
Tobins Q-Ratio = 4.47 (Enterprise Value 214b / Total Assets 47.9b)
Interest Expense / Debt = 3.90% (Interest Expense 341.7m / Debt 8.76b)
Taxrate = 15.50% (607.9m / 3.92b)
NOPAT = 3.57b (EBIT 4.23b * (1 - 15.50%))
Current Ratio = 1.75 (Total Current Assets 7.81b / Total Current Liabilities 4.46b)
Debt / Equity = 0.26 (Debt 8.76b / totalStockholderEquity, last quarter 33.7b)
Debt / EBITDA = 0.86 (Net Debt 5.32b / EBITDA 6.19b)
Debt / FCF = 1.17 (Net Debt 5.32b / FCF TTM 4.57b)
Total Stockholder Equity = 33.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.95% (Net Income 3.31b / Total Assets 47.9b)
RoE = 9.79% (Net Income TTM 3.31b / Total Stockholder Equity 33.9b)
RoCE = 10.29% (EBIT 4.23b / Capital Employed (Equity 33.9b + L.T.Debt 7.24b))
RoIC = 8.07% (NOPAT 3.57b / Invested Capital 44.3b)
WACC = 11.87% (E(209b)/V(218b) * Re(12.23%) + D(8.76b)/V(218b) * Rd(3.90%) * (1-Tc(0.16)))
Discount Rate = 12.23% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -82.22 | Cagr: -0.74%
[DCF] Terminal Value 67.46% ; FCFF base≈4.06b ; Y1≈4.65b ; Y5≈6.84b
[DCF] Fair Price = 119.1 (EV 63.3b - Net Debt 5.32b = Equity 58.0b / Shares 487.1m; r=11.87% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -35.06 | EPS CAGR: -9.35% | SUE: 4.0 | # QB: 2
Revenue Correlation: -9.16 | Revenue CAGR: -1.17% | SUE: 2.93 | # QB: 9
EPS current Quarter (2026-07-31): EPS=3.32 | Chg30d=+10.95% | Revisions=+86% | Analysts=26
EPS current Year (2026-10-31): EPS=12.34 | Chg30d=+7.69% | Revisions=+87% | GrowthEPS=+58.4% | GrowthRev=+33.7%
EPS next Year (2027-10-31): EPS=14.77 | Chg30d=+12.38% | Revisions=+87% | GrowthEPS=+19.7% | GrowthRev=+14.9%
[Analyst] Revisions Ratio: +87%